Accelerating your Microneedle Array Patch (MAP) commercialization​

Navigating the clinical and regulatory pathways are amongst the key barriers to MAP commercialization. Characterising the complex interaction between microneedle arrays and the patients’ skin is a significant challenge!

Leading MAP development teams are now realising the benefits provided by Optical Coherence Tomography (OCT), enabling them to visualise microneedle insertion, in vivo, in real time.

Click here to arrange your online demonstration. OCT provides rapid, non-invasive and repeatable quantification of key parameters to speed and inform your MAP development and regulatory path, including:

– In vivo visualisation of microneedle insertion
– Insertion depth, in real-time
– Needle dissolution and swelling
– Skin Inflammatory vascular response
– Kinetics of device created skin defects

 

Sign-Up to VivoScene: The VivoSight Community Newsletter

Book a demonstration

Learn how OCT provides rapid, non-invasive and repeatable quantification of key parameters to speed and inform your MAP development and regulatory path.
VivoScene

Sign up for our community newsletter – what matters in dermal OCT imaging, free to your inbox, every two months.

By signing up I agree my information will be processed in accordance with our Privacy Policy